NCT03289910 · MORE INFO

Limitations, agreements, and source contact

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · Source last updated 2026-06-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: JHCCCRO@jhmi.edu
organization: Johns Hopkins University
phone: 4439273568
title: Grants Administrative Manager

Complete source fields

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: JHCCCRO@jhmi.edu
organization: Johns Hopkins University
phone: 4439273568
title: Grants Administrative Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice